World Wires · story 124651 · corroborated · 1 source(s)

Biochemical reassessment of the activation of PANK1 by SGLT2 inhibitors

Although SGLT2 inhibitors (SGLT2i) show cardiovascular benefits in addition to glycemic control, their molecular target for cardiovascular effect remains u

Open in the desk

Coverage

• Biochemical reassessment of the activation of PANK1 by SGLT2 inhibitors bioRxiv (new preprints) · tier C · clear net · 2026-11-13 00:00 UTC

What this site indexes